Literature DB >> 15593124

NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation.

Gerben Bouma1, Tatjana Nikolic, Jojanneke M C Coppens, Cornelia G van Helden-Meeuwsen, Pieter J M Leenen, Hemmo A Drexhage, Silvano Sozzani, Marjan A Versnel.   

Abstract

The accumulation of macrophages (M Phi) and dendritic cells (DC) in the pancreas plays a crucial role in the pathogenesis of autoimmune diabetes. We studied the recruitment of monocytes, M Phi and DC to sites of inflammation, i.e. the peritoneal cavity and a subcutaneously elicited air pouch in the NOD mouse model of autoimmune diabetes. The leukocyte recruitment was studied from 1 to 7 days after injection of thioglycollate (peritoneum), C5a (peritoneum, air pouch), CCL2 and CCL3 (air pouch). C57BL/6 and BALB/c mice served as controls. Morphological and flow cytometric analysis of the recruited cells was performed, IL-1 beta, TNF-alpha, IL-6, IL-12 and IL-10 in exudates measured, and in vitro CCL2-chemotaxis of exudate M Phi (Boyden chamber) determined. NOD mice were strongly impaired in the recruitment of M Phi, DC, monocytes, and granulocytes. Chemokine-injected air pouches of NOD mice showed an increased IL-10 and a decreased IL-1 beta level, while the other cytokines were normally or very lowly expressed. In addition, NOD exudate M Phi displayed an impaired in vitro CCL2-induced migration. Our data show that NOD mice have an impaired ability to recruit leukocytes into sites of inflammation elicited in the peritoneum and the air pouch. A raised IL-10/IL-1 beta ratio at these sites and a deficient migratory capacity of NOD monocytes are important determinants in this impairment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15593124     DOI: 10.1002/eji.200425513

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes.

Authors:  G Bouma; J M C Coppens; W-K Lam-Tse; W Luini; K Sintnicolaas; W H Levering; S Sozzani; H A Drexhage; M A Versnel
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

2.  Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia.

Authors:  Johannes Fahrmann; Dmitry Grapov; Jun Yang; Bruce Hammock; Oliver Fiehn; Graeme I Bell; Manami Hara
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-07       Impact factor: 4.310

3.  Untreated type 1 diabetes increases sepsis-induced mortality without inducing a prelethal cytokine response.

Authors:  Marcin F Osuchowski; Florin L Craciun; Elizabeth Schuller; Corneliu Sima; Robert Gyurko; Daniel G Remick
Journal:  Shock       Date:  2010-10       Impact factor: 3.454

4.  Rescuing of deficient killing and phagocytic activities of macrophages derived from non-obese diabetic mice by treatment with geldanamycin or heat shock: potential clinical implications.

Authors:  Virginia Loreto Vega; Wisler Charles; Laura E Crotty Alexander; Laura E Crotty Alexander
Journal:  Cell Stress Chaperones       Date:  2011-05-29       Impact factor: 3.667

5.  Exploitation of Synthetic mRNA To Drive Immune Effector Cell Recruitment and Functional Reprogramming In Vivo.

Authors:  Yitian Xu; Lu Huang; Jonathan L Kirschman; Daryll A Vanover; Pooja M Tiwari; Philip J Santangelo; Xiling Shen; David G Russell
Journal:  J Immunol       Date:  2018-12-12       Impact factor: 5.422

6.  Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells.

Authors:  Martin A Kriegel; Chozhavendan Rathinam; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-10       Impact factor: 11.205

7.  Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice.

Authors:  Savita Khanna; Sabyasachi Biswas; Yingli Shang; Eric Collard; Ali Azad; Courtney Kauh; Vineet Bhasker; Gayle M Gordillo; Chandan K Sen; Sashwati Roy
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

8.  Diabetes-induced alteration of F4/80+ macrophages: a study in mice with streptozotocin-induced diabetes for a long term.

Authors:  Haixia Ma; Guangwei Liu; Wenjun Ding; You Wu; Lu Cai; Yong Zhao
Journal:  J Mol Med (Berl)       Date:  2008-01-30       Impact factor: 4.599

9.  Type I interferons inhibit the generation of tumor-associated macrophages.

Authors:  Lance U'Ren; Amanda Guth; Debra Kamstock; Steven Dow
Journal:  Cancer Immunol Immunother       Date:  2009-10-14       Impact factor: 6.968

10.  Altered phenotype of peripheral blood dendritic cells in pediatric type 1 diabetes.

Authors:  Janne K Nieminen; Jukka Vakkila; Harri M Salo; Nina Ekström; Taina Härkönen; Jorma Ilonen; Mikael Knip; Outi Vaarala
Journal:  Diabetes Care       Date:  2012-07-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.